Javed Nismat, Itare Vikram, Otobo Emamuzo O, Montesano Yordano, Jadhav Preeti, Krim Nassim
BronxCare Health System, Bronx, NY, USA.
Division of Cardiology, BronxCare Health System, NY, USA.
J Community Hosp Intern Med Perspect. 2025 May 5;15(3):90-93. doi: 10.55729/2000-9666.1483. eCollection 2025.
Amphetamine use is associated with increasing rates of cardiovascular risks, such as pulmonary hypertension, arrhythmias, and atherosclerosis. A 47-year-old woman experienced an inferior MI after taking the weight loss drug phentermine. She presented with chest pain, shortness of breath, and vomiting. Initial examination showed low blood pressure and slow heart rate. Subsequent tests revealed elevated cardiac enzyme levels and ST elevations on EKG. A coronary angiogram showed a blockage in the right coronary artery. She underwent a successful procedure to open the artery. The case highlights the heightened cardiovascular risks associated with amphetamine use, even in individuals without existing heart conditions. Research and clinical guidelines are crucial for better prediction, diagnosis, and management of such complications.
使用苯丙胺与心血管疾病风险增加有关,如肺动脉高压、心律失常和动脉粥样硬化。一名47岁的女性在服用减肥药物芬特明后发生下壁心肌梗死。她出现胸痛、呼吸急促和呕吐症状。初步检查显示血压低、心率慢。后续检查发现心肌酶水平升高,心电图显示ST段抬高。冠状动脉造影显示右冠状动脉堵塞。她接受了成功的动脉开通手术。该病例凸显了使用苯丙胺相关的心血管风险增加,即使是没有现有心脏疾病的个体。研究和临床指南对于更好地预测、诊断和管理此类并发症至关重要。